BBA
BIO icon

Braun-Bostich & Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

Braun-Bostich & Associates’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-453
Closed -$234K – 79
2020
Q3 		$234K Buy
453
+442
+4,018% +$224K 0.23% 75
2020
Q2 		$5K Buy
+11
New +$4.85K ﹤0.01% 261

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Braun-Bostich & Associates's BIO Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 453 shares — an estimated $234K sold.

Braun-Bostich & Associates first reported a position in BIO in Q2 2020 and held it in 2 quarters. The position peaked at $234K in Q3 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

  • Braun-Bostich & Associates reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 453 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $234K.
  • Braun-Bostich & Associates first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 2 quarters.
  • Braun-Bostich & Associates's Bio-Rad Laboratories Class A position peaked at $234K in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.